enGene Holdings Inc. Warrants
General ticker "ENGNW" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $424.5M (TTM average)
enGene Holdings Inc. Warrants follows the US Stock Market performance with the rate: 26.9%.
Estimated limits based on current volatility of 32.9%: low 0.20$, high 0.39$
Factors to consider:
- Total employees count: 33 as of 2023
- Current price 74.9% below estimated low
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-10-31 to 2026-10-31
- 2024-10-31 to 2025-10-31 estimated range: [0.97$, 3.16$]
- 2025-10-31 to 2026-10-31 estimated range: [0.93$, 2.99$]
Short-term ENGNW quotes
Long-term ENGNW plot with estimates
Financial data
| YTD | 2023-10-31 | 2024-10-31 | 2025-10-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $26.06MM | $62.30MM | $123.17MM |
| Operating Income | $-26.06MM | $-62.30MM | $-123.17MM |
| Non-Operating Income | $-73.84MM | $7.14MM | $5.86MM |
| Interest Expense | $4.95MM | $2.80MM | $2.99MM |
| R&D Expense | $16.46MM | $38.31MM | $94.48MM |
| Income(Loss) | $-99.90MM | $-55.16MM | $-117.30MM |
| Taxes | $0.02MM | $-0.02MM | $0.00MM |
| Profit(Loss)* | $-99.92MM | $-55.14MM | $-117.30MM |
| Stockholders Equity | $72.49MM | $272.61MM | $167.71MM |
| Assets | $86.96MM | $311.17MM | $221.47MM |
| Operating Cash Flow | $-24.74MM | $-48.28MM | $-99.24MM |
| Capital expenditure | $0.32MM | $0.93MM | $1.49MM |
| Investing Cash Flow | $-0.32MM | $-125.95MM | $-25.14MM |
| Financing Cash Flow | $86.15MM | $265.72MM | $1.52MM |
| Earnings Per Share** | $-4.24 | $-1.24 | $-2.29 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.